Omnicell - OMCL Stock Forecast, Price & News

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OMCL shares.
View OMCL analyst ratings or view top-rated stocks.

8 brokerages have issued twelve-month price objectives for Omnicell's shares. Their OMCL share price forecasts range from $54.00 to $120.00. On average, they expect the company's stock price to reach $71.67 in the next twelve months. This suggests a possible upside of 28.5% from the stock's current price.
View analysts price targets for OMCL or view top-rated stocks among Wall Street analysts.

Omnicell's stock was trading at $50.42 at the start of the year. Since then, OMCL stock has increased by 10.6% and is now trading at $55.77.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our OMCL earnings forecast.

Omnicell, Inc. (NASDAQ:OMCL) released its quarterly earnings results on Tuesday, November, 2nd. The company reported $1.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.63 by $0.45. The business earned $296.40 million during the quarter, compared to the consensus estimate of $283.82 million. Omnicell had a trailing twelve-month return on equity of 7.11% and a net margin of 0.44%. During the same period in the previous year, the company posted $0.40 EPS.

ETFs with the largest weight of Omnicell (NASDAQ:OMCL) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Healthcare Technology and Innovation ETF (HTEC), ROBO Global Robotics & Automation ETF (ROBO), Global X Robotics & Artificial Intelligence ETF (BOTZ), Invesco Nasdaq Future Gen 200 ETF (QQQS), Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC) and First Trust Multi-Manager Small Cap Opportunities ETF (MMSC).

Omnicell updated its first quarter 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share (EPS) guidance of $0.04-$0.14 for the period, compared to the consensus EPS estimate of $0.19. The company issued revenue guidance of $273.00 million-$283.00 million, compared to the consensus revenue estimate of $275.46 million.

150 employees have rated Omnicell Chief Executive Officer Randall A. Lipps on Glassdoor.com. Randall A. Lipps has an approval rating of 68% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicell investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Adobe (ADBE), Micron Technology (MU), NVIDIA (NVDA), Applied Materials (AMAT), Alibaba Group (BABA) and Intel (INTC).

Omnicell trades on the NASDAQ under the ticker symbol "OMCL."

Omnicell's stock is owned by many different institutional and retail investors. Top institutional investors include Conestoga Capital Advisors LLC (3.64%), Clearbridge Investments LLC (2.65%), Geneva Capital Management LLC (2.17%), ArrowMark Colorado Holdings LLC (1.92%), Geode Capital Management LLC (1.89%) and Dimensional Fund Advisors LP (1.71%). Insiders that own company stock include Christine Marie Mellon, Dan S Johnston, James T Judson, Joanne B Bauer, Joseph Brian Spears, Peter J Kuipers, Randall A Lipps, Robin Gene Seim and Scott Peter Seidelmann.
View institutional ownership trends.

Shares of OMCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OMCL stock can currently be purchased for approximately $55.77.

Omnicell (NASDAQ:OMCL) has a market capitalization of $2.51 billion and generates $1.30 billion in revenue each year. The company earns $5.65 million in net income (profit) each year or $0.10 on an earnings per share basis.

The company employs 4,230 workers across the globe.

Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The official website for the company is www.omnicell.com. The company can be reached via phone at (650) 251-6100, via email at ir@omnicell.com, or via fax at 847-596-3402.